Skip to main content

Table 2 Frequency of group 1, 2A, 2B, 3 and unclassified HPV genotypes among NILM, low grade SIL and high grade SIL

From: Prevalence of “unclassified” HPV genotypes among women with abnormal cytology

Species

HPV genotypea

All samples

n = 337 (%)

NILM

n = 96 (%)

LSIL

n = 226 (%)

HSIL

n = 15 (%)

 

HPV Negative

107 (31.8)

61 (63.5)

45 (20.0)

1 (6.7)

 

HPV Positive

230 (68.3)

35 (36.5)

181 (80.0)

14 (93.3)

 

Group 1

A9

HPV16

40 (11.9)

5 (5.2)

30 (13.3)

5 (33.3)

A7

HPV18

13 (3.9)

2 (2.1)

10 (4.4)

1 (6.7)

A9

HPV31

18 (5.3)

0

17 (7.5)

1 (6.7)

A9

HPV33

11 (3.3)

1 (1.0)

9 (3.9)

1 (6.7)

A9

HPV35

2 (0.6)

0

1 (0.4)

1 (6.7)

A7

HPV39

7 (2.1)

1 (1.0)

5 (2.2)

1 (6.7)

A7

HPV45

7 (2.1)

0

7 (3.1)

0

A5

HPV51

6 (1.8)

0

5 (2.2)

1 (6.7)

A9

HPV52

10 (3.0)

4 (4.2)

6 (2.7)

0

A6

HPV56

10 (3.0)

3 (3.1)

5 (2.2)

2 (13.3)

A9

HPV58

8 (2.4)

3 (3.1)

5 (2.2)

0

A7

HPV59

7 (2.1)

2 (2.1)

5 (2.2)

0

 

Total Group 1

139 (41.3)

21 (21.9)

105 (46.5)

13 (86.7)

 

Group 2A

A7

HPV68

3 (0.9)

1 (1.0)

2 (0.8)

0

 

Group 2B

A6

HPV53

22 (6.5)

2 (2.1)

19 (8.4)

1 (7.1)

A6

HPV66

21 (6.2)

1 (1.0)

17 (7.5)

3 (21.4)

A9

HPV67

3 (0.9)

0

3 (1.3)

0

A7

HPV70

5 (1.5)

0

5 (2.2)

0

A11

HPV73

2 0.6)

0

2 (0.9)

0

A5

HPV82

2 (0.6)

1 (1.0)

1 (0.4)

0

A11

HPV34

1 (0.3)

0

1 (0.4)

0

A7

HPV85

1 (0.3)

0

1 (0.4)

0

 

Total Group 2B

57 (16.9)

4 (4.2)

49 (21.7)

4 (26.7)

 

Group 3

A10

HPV6

8 (2.4)

2 (2.1)

6 (2.7)

0

A10

HPV11

1 (0.3)

0

1 (0.4)

0

 

Total Group 3

9 (2.7)

2 (2.1)

7 (3.1)

0

 

Unclassified

A3

HPV81

7 (2.1)

1 (1.0)

6 (2.7)

0

A1

HPV42

5 (1.5)

0

5 (2.2)

0

A3

HPV62

6 (1.8)

1 (1.0)

5 (2.2)

0

A10

HPV55

4 (1.2)

1 (1.0)

3 (1.3)

0

A3

HPV89

4 (1.2)

3 (3.1)

1 (0.4)

0

A8

HPV91

4 (1.2)

0

4 (1.8)

0

A13

HPV54

3 (0.9)

0

3 (1.3)

0

A14

HPV90

3 (0.9)

1 (1.0)

2 (0.9)

0

A3

HPV84

2 (0.6)

1 (1.0)

1 (0.4)

0

A3

HPV61

1 (0.3)

0

1 (0.4)

0

A3

HPV83

1 (0.3)

0

1 (0.4)

0

B1

HPV12

1 (0.3)

0

1 (0.4)

0

 

Total Unclassified

41 (12.2)

8 (8.3)

33 (14.6)

0

  1. aType-specific prevalence includes HPVs in single or multiple infections